Download
10072_2024_Article_7545.pdf 995,94KB
WeightNameValue
1000 Titel
  • Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review
1000 Autor/in
  1. Barba, Lorenzo |
  2. Carrubba, Carmelo |
  3. Spindler, Kai |
  4. Weise, Christopher M. |
  5. Sachs, Torben |
  6. Foschi, Matteo |
  7. D’Anna, Lucio |
  8. Sehm, Bernhard |
  9. Ibe, Richard |
  10. Elolf, Erck |
  11. Strauss, Christian |
  12. Otto, Markus |
  13. Mensch, Alexander |
  14. Abu-Rumeileh, Samir |
1000 Verlag Springer International Publishing
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-29
1000 Erschienen in
1000 Quellenangabe
  • 45(9):4151-4159
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s10072-024-07545-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11306538/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>Posterior reversible encephalopathy syndrome (PRES) is an acute neurological condition associated with different etiologies, including antibiotic therapy. To date, most data regarding antibiotic-related PRES are limited to case reports and small case series. Here, we report a novel case description and provide a systematic review of the clinico-radiological characteristics and prognosis of available cases of PRES associated with antibiotic therapy. We performed a systematic literature search in PubMed and Scopus from inception to 10 January 2024, following PRISMA guidelines and a predefined protocol. The database search yielded 12 subjects (including our case). We described the case of a 55-year-old female patient with PRES occurring one day after administration of metronidazole and showing elevated serum neurofilament light chain protein levels and favorable outcome. In our systematic review, antibiotic-associated PRES was more frequent in female patients (83.3%). Metronidazole and fluoroquinolones were the most reported antibiotics (33.3% each). Clinical and radiological features were comparable to those of PRES due to other causes. Regarding the prognosis, about one third of the cases were admitted to the intensive care unit, but almost all subjects (90.0%) had a complete or almost complete clinical and radiological recovery after prompt cessation of the causative drug. Antibiotic-associated PRES appears to share most of the characteristics of classic PRES. Given the overall good prognosis of the disease, it is important to promptly diagnose antibiotic-associated PRES and discontinue the causative drug.</jats:p>
1000 Sacherschließung
lokal Female [MeSH]
lokal Anti-Bacterial Agents/therapeutic use [MeSH]
lokal Neurofilament light chain
lokal Posterior Leukoencephalopathy Syndrome/diagnostic imaging [MeSH]
lokal Posterior reversible encephalopathy syndrome
lokal Humans [MeSH]
lokal Review Article
lokal Metronidazole
lokal Middle Aged [MeSH]
lokal Metronidazole/adverse effects [MeSH]
lokal Anti-Bacterial Agents/adverse effects [MeSH]
lokal Posterior Leukoencephalopathy Syndrome/chemically induced [MeSH]
lokal Adverse drug reactions
lokal Antibiotics
lokal PRES
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/QmFyYmEsIExvcmVuem8=|https://frl.publisso.de/adhoc/uri/Q2FycnViYmEsIENhcm1lbG8=|https://frl.publisso.de/adhoc/uri/U3BpbmRsZXIsIEthaQ==|https://frl.publisso.de/adhoc/uri/V2Vpc2UsIENocmlzdG9waGVyIE0u|https://frl.publisso.de/adhoc/uri/U2FjaHMsIFRvcmJlbg==|https://frl.publisso.de/adhoc/uri/Rm9zY2hpLCBNYXR0ZW8=|https://frl.publisso.de/adhoc/uri/ROKAmUFubmEsIEx1Y2lv|https://frl.publisso.de/adhoc/uri/U2VobSwgQmVybmhhcmQ=|https://frl.publisso.de/adhoc/uri/SWJlLCBSaWNoYXJk|https://frl.publisso.de/adhoc/uri/RWxvbGYsIEVyY2s=|https://frl.publisso.de/adhoc/uri/U3RyYXVzcywgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/T3R0bywgTWFya3Vz|https://frl.publisso.de/adhoc/uri/TWVuc2NoLCBBbGV4YW5kZXI=|https://orcid.org/0000-0003-0631-8506
1000 Hinweis
  • DeepGreen-ID: 112b9d1fc4bb4703ba002c227baf4690 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Martin-Luther-Universität Halle-Wittenberg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Martin-Luther-Universität Halle-Wittenberg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6518593.rdf
1000 Erstellt am 2025-07-05T12:20:57.465+0200
1000 Erstellt von 322
1000 beschreibt frl:6518593
1000 Zuletzt bearbeitet 2025-08-15T20:36:58.272+0200
1000 Objekt bearb. Fri Aug 15 20:36:58 CEST 2025
1000 Vgl. frl:6518593
1000 Oai Id
  1. oai:frl.publisso.de:frl:6518593 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source